title: Evaluation of the experimental pathogenicity of some Cryptococcus species in normal and cyclophosphamide-immunodepressed mice.
abstract: The pathogenic potential of distinct Cryptococcus species has been evaluated in mice rendered leukopenic by one or two injections of the potent immunosuppressive drug cyclophosphamide (Cy). Pathogenicity assessment included enumeration of viable cryptococcal cells in animal organs and histopathological observations. It was found that putatively non-pathogenic species of Cryptococcus, in particular C. cereanus and C. albidus, showed significant lethality for Cy-treated mice. In Cy-immunodepressed mice, challenged with the infectious cryptococcal cells two days after pharmacological treatment, a significant decrease of LD50 (equivalent to at least one order of magnitude) was observed for all Cryptococcus species. However, the pathogenicity enhancement due to Cy immunodepression was greater with C. neoformans. In all cases, brain and kidney were the most invaded tissues as also evidenced by histopathological examination, which showed the typical cystic lesion. All the observations made point to the conclusion that the pathogenic potential, for the immunomodulated host, of Cryptococci other than C. neoformans is significant being quantitatively and not qualitatively different from that of C. neoformans, as evidenced by a similar organotropism and similar type of histological lesions in the target organs (brain and kidney).
authors.affiliation: Medical Mycology Unit, Istituto Superiore di Sanità, Rome, Italy.
authors.forename: F
authors.initials: F
authors.lastname: De Bernardis
authors.forename: E
authors.initials: E
authors.lastname: Palliola
authors.forename: R
authors.initials: R
authors.lastname: Lorenzini
authors.forename: G
authors.initials: G
authors.lastname: Antonucci
mesh_terms: D000818:Animals; D001921:Brain / Q000382:microbiology / Q000473:pathology; D003453:Cryptococcosis / Q000382:microbiology* / Q000473:pathology; D003454:Cryptococcus / Q000187:drug effects / Q000472:pathogenicity*; D003455:Cryptococcus neoformans / Q000187:drug effects / Q000472:pathogenicity; D003520:Cyclophosphamide / Q000494:pharmacology*; D007165:Immunosuppression Therapy; D007668:Kidney / Q000382:microbiology / Q000473:pathology; D007958:Leukocyte Count / Q000187:drug effects; D008099:Liver / Q000473:pathology; D008168:Lung / Q000382:microbiology / Q000473:pathology; D051379:Mice
chemical_list: D003520:Cyclophosphamide